RxDoctor Payments Data

Kristen Colvert, NP

Nurse Practitioner · Newburgh, INNPI 1104509025

Payments from drug & device makers

$1,665in general payments, 2019–2025

Across 73 payments — averaging $22.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$441
  • Abiomed$252
  • Merck$184
  • Pfizer$141
  • E.r. Squibb & Sons, L.L.C.$128
  • Johnson & Johnson$113
  • plus $406 from 10 others

What the payments were for

  • Food & beverage$1,665100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,665 in reported general payments places this provider in the 80th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$50,258
Medicare patients
359
Services billed
501

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan61$64,337
JardianceEmpagliflozin61$49,251
EliquisApixaban42$37,697
Repatha SureclickEvolocumab29$34,863
FarxigaDapagliflozin Propanediol29$29,522
XareltoRivaroxaban15$16,118
Metoprolol Succinate135$1,461
Ezetimibe45$942
Atorvastatin Calcium97$602
Amlodipine Besylate102$530
Carvedilol55$382
Diltiazem 24hr Er (Cd)Diltiazem Hcl15$377
Losartan Potassium64$377
Chlorthalidone21$343
Rosuvastatin Calcium53$334

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$56$49,25161 claims
PfizerEliquis$141$37,69742 claims
AstraZenecaFarxiga$18$29,52229 claims
Johnson & JohnsonXarelto$113$16,11815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Newburgh

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →